| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/25/1996 | WO1996022081A1 Liquid stable vitamin c compositions and delivery systems, and methods of making and uses thereof |
| 07/25/1996 | WO1996022080A1 Pharmaceutical excipient having improved compressibility |
| 07/25/1996 | WO1996022079A2 Lotions containing fatty acid derivatives |
| 07/25/1996 | WO1996022030A1 Edible products having inorganic coatings |
| 07/25/1996 | WO1996022028A1 Medicated animal foodstuffs |
| 07/25/1996 | WO1996010429A3 Improved transdermal device having decreased delamination |
| 07/25/1996 | WO1996008229A3 Matrix for transdermal drug delivery |
| 07/25/1996 | DE19501288A1 Fettsäurederivate enthaltende Lotionen Fatty acid derivatives containing lotions |
| 07/25/1996 | DE19500977A1 Feste Arzneimittel mit in polymerem Material verteiltem Wirkstoff Solid pharmaceutical distributed in polymeric material agent |
| 07/25/1996 | CA2210851A1 Edible products having inorganic coatings |
| 07/25/1996 | CA2210800A1 Biopolymers derived from hydrolyzable diacid fats |
| 07/25/1996 | CA2209931A1 The use of activated protein c for preparing a pharmaceutical preparation |
| 07/24/1996 | EP0723013A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/24/1996 | EP0722734A1 NADH and NADPH therapeutic agents for nasal, sublingual, rectal and dermal administration |
| 07/24/1996 | EP0722732A1 Long-acting drug formulation containing pyrimidinedione derivatives |
| 07/24/1996 | EP0722730A1 Controlled release oxycodone compositions |
| 07/24/1996 | EP0722721A1 Food-like drug |
| 07/24/1996 | EP0722720A1 Novel sugar coating composition for application to compressed medicinal tablets |
| 07/24/1996 | EP0722719A1 Process for preparing flavano-lignan preparations |
| 07/24/1996 | EP0722718A2 Lipid vesicles having an alkyd as a wall-forming material |
| 07/24/1996 | EP0722670A1 Oleaginous-containing matrix materials in edible protein compositions |
| 07/24/1996 | EP0722656A1 Device for controlled release of drugs, designed for attachment to or on an animal and method for producing such a device |
| 07/24/1996 | EP0722470A1 Multifunctional organic polymers |
| 07/24/1996 | EP0722341A1 Improvements in and relating to vaccines |
| 07/24/1996 | EP0722338A1 Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| 07/24/1996 | EP0722327A1 Improvements relating to antibacterial compositions |
| 07/24/1996 | EP0722323A1 Compositions containing prostaglandin e1 and/or troxerutine complexed with phosphatidylcholine for topical treatment of erectile impotence |
| 07/24/1996 | EP0722318A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 07/24/1996 | EP0722317A1 Liposomes containing particulate materials |
| 07/24/1996 | EP0722316A1 New emulsion formulation |
| 07/24/1996 | EP0722315A1 Uv protective film-forming composition |
| 07/24/1996 | EP0722314A1 Pellet for administration to ruminants |
| 07/24/1996 | EP0722313A1 Viscoelastic compositions of fluorinated organic compounds |
| 07/24/1996 | EP0722312A1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 07/24/1996 | EP0714300A4 Methods for modulating the human sexual response |
| 07/24/1996 | EP0630237B1 Method of producing porous delivery devices |
| 07/24/1996 | EP0615438B1 A carbohydrate glass matrix for the sustained release of a therapeutic agent |
| 07/24/1996 | EP0598116B1 Fat emulsion |
| 07/24/1996 | EP0527153B1 Aqueous maltodextrin and cellulosic polymer film coatings |
| 07/24/1996 | CN1127476A Plasma-like solution |
| 07/24/1996 | CN1127474A Dried hydrogel from hydrophylic-hygroscopic polymer |
| 07/24/1996 | CN1127471A Compositions for inhalation |
| 07/24/1996 | CN1127470A Once-a-day methoprolol oral dosage form |
| 07/24/1996 | CN1127469A Sustained release excipient |
| 07/24/1996 | CN1127141A Molded articles and method of producing the same |
| 07/24/1996 | CN1127134A Hematopoietic tablet and producing process |
| 07/24/1996 | CN1127133A Pharynx and larynx health care products and production tech. |
| 07/24/1996 | CN1127132A Medicinal composite for hysteromyoma and preparing method |
| 07/24/1996 | CN1127131A Making method of oral capsule for curing difficult and complicated fracture |
| 07/24/1996 | CN1127127A Oral liquid for prompting walking |
| 07/24/1996 | CN1127124A Traditional Chinese medicine for curing and preventing hepatopathy and preparing method |
| 07/24/1996 | CN1127119A Compound venin gynostemma pentaphyllum entric solubility capsule |
| 07/24/1996 | CN1127112A Quick-acting injection for bromhidrosis and preparation thereof |
| 07/24/1996 | CN1032348C Method for prepn. of stable immunogen composition for oral administration |
| 07/24/1996 | CA2167663A1 Controlled release device and process for preparing the same |
| 07/23/1996 | US5539129 Nonionic amphiphilic compounds derived from glycerol, a process for preparing them, and corresponding intermediate compounds |
| 07/23/1996 | US5539000 Spray-chilled nabumetone |
| 07/23/1996 | US5538989 Fenbendazole formulations |
| 07/23/1996 | US5538959 Analgesic composition for treatment of migraine headaches |
| 07/23/1996 | US5538951 Dipeptides of glutamic acid and tryptophan for immunology |
| 07/23/1996 | US5538883 Maltose-trehalose converting enzyme |
| 07/23/1996 | US5538866 Immunoassay; medical diagnosis |
| 07/23/1996 | US5538739 Sustained release formulations of water soluble peptides |
| 07/23/1996 | US5538738 Retard systems for the sustained release of medicinal and/or biological valuable materials from a depot carrier material |
| 07/23/1996 | US5538737 Water-in-oil emulsion in capsule form |
| 07/23/1996 | US5538736 Drug delivery, two reservoirs, vasodilators, bronchodilators, smoking withdrawal |
| 07/23/1996 | US5538735 Method of making a drug delivery system using hollow fibers |
| 07/23/1996 | US5538734 5-methyltetrahydrofolic acid, 5-formyl-tetrahydrofolic acid and their pharmaceutically acceptable salts for use in the therapy of depressive disturbances |
| 07/23/1996 | US5538733 Poultry |
| 07/23/1996 | US5538732 Dermatology |
| 07/23/1996 | US5538728 Hydrophilic polymer-silicate mineral complex material and use thereof |
| 07/23/1996 | US5538726 Increasing residence time in tumor, injecting protein agglomerates to block blood circulation to and from tumor region |
| 07/23/1996 | US5538721 Stabilization of aminosteroids for topical ophthalmic and other applications |
| 07/23/1996 | US5538125 Indexing and feeding systems for apparatus for gelatin coating tablets |
| 07/23/1996 | CA2002945C Solid encapsulated medicament and process and apparatus for preparing same |
| 07/23/1996 | CA1338467C Pharmaceutical composition, pharmaceutical granulate and process for their preparation |
| 07/23/1996 | CA1338466C Manipulation of ovulation and spawning in fish |
| 07/18/1996 | WO1996021731A2 Stabilized external guide sequences |
| 07/18/1996 | WO1996021658A1 Hydrophobic taxane derivatives |
| 07/18/1996 | WO1996021481A1 Method of altering composition of nutritional product |
| 07/18/1996 | WO1996021470A2 Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy |
| 07/18/1996 | WO1996021464A1 Compositions for the delivery of antigens |
| 07/18/1996 | WO1996021463A2 New applications of lysozyme dimer |
| 07/18/1996 | WO1996021462A1 Pharmaceutical compositions comprising a superoxide dismutase |
| 07/18/1996 | WO1996021461A1 A stabilized pharmaceutical formulation comprising a growth hormone and leu-his-leu |
| 07/18/1996 | WO1996021460A1 A stabilized pharmaceutical formulation comprising a growth hormone and x-lys |
| 07/18/1996 | WO1996021459A1 A stabilized pharmaceutical formulation comprising a growth hormone and lys-x |
| 07/18/1996 | WO1996021453A1 Enrofloxacine injection or infusion solutions |
| 07/18/1996 | WO1996021448A1 Resin particle, medical material and pharmaceutical preparation containing said resin particle |
| 07/18/1996 | WO1996021446A1 Pharmaceutical composition with anti-alcoholic and nootropic properties |
| 07/18/1996 | WO1996021439A1 Pharmaceutical composition containing fenofibrate and polyglycolized glycerides |
| 07/18/1996 | WO1996021434A1 Transdermal therapeutic system for dispensing (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts |
| 07/18/1996 | WO1996021433A1 Plaster containing estradiol |
| 07/18/1996 | WO1996021432A1 Delivery of active substances by way of mucosal surfaces of pharyngeal and esophageal regions |
| 07/18/1996 | WO1996021431A1 Reduction of electrostatic forces between magnesium trisilicate adsorbates |
| 07/18/1996 | WO1996021430A1 Treatment of attention-deficit/hyperactivity disorder |
| 07/18/1996 | WO1996021429A1 Pharmaceutical excipient having improved compressibility |
| 07/18/1996 | WO1996021428A1 Solid medicament form with active agent distributed in polymer material |
| 07/18/1996 | WO1996021427A1 Liquid polymer delivery system |
| 07/18/1996 | WO1996021421A1 Nutrient medium for use as a culture medium for epidermal cells, and uses thereof |